75 Activated microglia do not upregulate translocator protein 28. Dickens AM, et al. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med. Mar 2014;55(3):466-72. doi:10.2967/ jnumed.113.125625 29. Veronese M, et al. Kinetic modelling of [(11)C] PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis. J Cereb Blood Flow Metab. Jul 2018;38(7):1227-1242. doi:10.1177/0271678X17712388 30. Wimberley C, et al. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of (18) F-DPA-714. J Nucl Med. Feb 2018;59(2):307-314. doi:10.2967/jnumed.117.195396 31. Banati RB. Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. Br Med Bull. 2003;65(1):121-31. doi:10.1093/bmb/65.1.121 32. Cosenza-Nashat M, et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol. Jun 2009;35(3):306-28. doi:10.1111/j.13652990.2008.01006.x 33. Vogel DY, et al. Human macrophage polarization in vitro: maturation and activation methods compared. Immunobiology. Sep 2014;219(9):695703. doi:10.1016/j.imbio.2014.05.002 34. Holtman IR, et al. Transcriptional control of microglia phenotypes in health and disease. J Clin Invest. Sep 1 2017;127(9):3220-3229. doi:10.1172/ JCI90604 35. Hendrickx DAE, et al. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology. J Neuroimmunol. Aug 15 2017;309:12-22. doi:10.1016/j. jneuroim.2017.04.007 36. Sasaki Y, et al. Iba1 is an actin-cross-linking protein in macrophages/microglia. Biochem Biophys Res Commun. Aug 17 2001;286(2):292-7. doi:10.1006/ bbrc.2001.5388 37. Ito D, et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res. Jun 1 1998;57(1):1-9. doi:10.1016/s0169328x(98)00040-0 38. Ohsawa K, et al. Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actinbundling activity. J Neurochem. Feb 2004;88(4):84456. doi:10.1046/j.1471-4159.2003.02213.x 39. Butovsky O, et al. Identification of a unique TGFbeta-dependent molecular and functional signature in microglia. Nat Neurosci. Jan 2014;17(1):131-43. doi:10.1038/nn.3599 40. Bennett ML, et al. New tools for studying microglia in the mouse and human CNS. Proc Natl Acad Sci U S A. Mar 22 2016;113(12):E1738-46. doi:10.1073/ pnas.1525528113 41. van Wageningen TA, et al. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. Acta Neuropathol Commun. Dec 11 2019;7(1):206. doi:10.1186/s40478-019-0850-z 42. Harberts E, et al. Translocator protein 18 kDa (TSPO) expression in multiple sclerosis patients. J Neuroimmune Pharmacol. Mar 2013;8(1):51-7. doi:10.1007/s11481-012-9397-5 "! " # "! " # ! ! " ! ! " "! " # "! " # A B C Figure S1. Number of microglia/macrophage markers in white matter lesions in MS. Numbers of positive cells per mm2 showing that nearly all TSPO+ cells in white matter MS lesions co‐localize with at least one or two microglia/ macrophage markers (a–c). Scale bar = 50μm. NAWM = normal appearing white matter, CA = chronic active.
RkJQdWJsaXNoZXIy MTk4NDMw